skip to main content
LOTERRE

LOTERRE

Chemical Entities of Biological Interest Ontology (CHEBI)

Choisissez le vocabulaire dans lequel chercher

Langue des données

| español English
Aide à la recherche

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > ureas > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > piperidines > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > N-acylpiperidine > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > amino acid derivative > phenylalanine derivative > L-phenylalanine derivative > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > amino acid derivative > phenylalanine derivative > L-phenylalanine derivative > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > amino acid derivative > proteinogenic amino acid derivative > L-phenylalanine derivative > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > amino acid derivative > proteinogenic amino acid derivative > L-phenylalanine derivative > N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide

Terme préférentiel

N-[(4-morpholin-4-ylpiperidin-1-yl)carbonyl]-L-phenylalanin-N-{(1S)-1-[(E)-2-(phenylsulfonyl)ethenyl]butyl}amide  

Concept(s) générique(s)

Appartient au groupe

URI

http://data.loterre.fr/ark:/67375/KFP-JJFDSJS6-W

Télécharger ce concept:

RDF/XML TURTLE JSON-LD Dernière modif. 25/03/2022